Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 280-285, December 2008

The Neuroprotection of Kappa Opioid Receptor Agonist BRL52537 is Partly Through Enhancing Endogenous GABA Function

  • Tsung-Ying Chen

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • Graduate Institute of Clinical Medicine, Department of Nursing, Tzu Chi University, Hualien, Taiwan
    • ,
  • Hsu-Tang Liu

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • ,
  • Chia-Ling Lee

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • ,
  • Jimmy Ong

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • ,
  • E-Jian Lee

      Affiliations

    • Neurophysiology Laboratory, National Cheng Kung University and Department of Surgery, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Ming-Hwang Shyr

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Anesthesiology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan

Received 20 November 2007; received in revised form 20 December 2007; accepted 15 January 2008.

Article Outline

Abstract 

Objective

We previously demonstrated that pretreatment with selective κ-opioid agonist BRL52537 hydrochloride [(κ)-1-(3,4-dichlorophenyl) acetyl-2-(1-pyrrolidinyl) methylpiperidine] provides ischemic neuroprotection following transient focal ischemia in rats. The present study was undertaken to determine whether the neuroprotection of BRL52537 attenuates ischemia-evoked efflux of GABA in the striatum in vivo following transient focal ischemia.

Materials and Methods

Using the intraluminal filament technique, halothane-anesthetized male Wistar rats (n = 20) were subjected to 2 hours of middle cerebral artery occlusion (MCAO). In a blinded, randomized fashion, rats were treated with saline (vehicle) or 1 mg/kg/hr BRL52537 started 30 minutes before MCAO and continued at 0.5 mL/hr until the 22nd hour of reperfusion. We also utilized in vivo microdialysis to measure extracellular levels of amino acids including glutamate and GABA in the striatum during the 2 hours of MCAO and 3 hours of reperfusion. Data are presented as mean ± standard error of the mean. Statistical analysis was performed using the unpaired Student's t test.

Results

Infarct volume of 26.2 ± 3.6% in the cortex and 42.9 ± 4.2% in the striatum were significantly attenuated in the BRL52537 group when compared with the control subjects (42.8 ± 5.7% in cortex; 74.0 ± 3.7% in striatum). Pretreatment with BRL52537 significantly increased microdialysate levels of GABA in the striatum during MCAO and early reperfusion, when compared with the control subjects. However, other amino acids did not show significant changes.

Conclusion

The data demonstrated that BRL52537 provided robust ischemic neuroprotection with altering ischemia-evoked efflux of GABA in the striatum during ischemia and early reperfusion.

Keywords:  GABA , Kappa opioid receptor , Neuroprotection

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Baskin DS , Kuroda H , Hosobuchi Y , Lee NM . Treatment of stroke with opiate antagonists–effects of exogenous antagonists and dynorphin 1-13 . Neuropeptides . 1985;5:307–310
  2. Fried RL , Nowak TS . Opioid peptide levels in gerbil brain after transient ischemia: lasting depletion of hippocampal dynorphin . Stroke . 1987;18:765–770
  3. Hosobuchi Y , Baskin DS , Woo SK . Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone . Science . 1982;215:69–71
  4. Zabramski JM , Spetzler RF , Selman WR , et al.   Naloxone therapy during focal cerebral ischemia evaluation in a primate model . Stroke . 1984;15:621–627
  5. Baskin DS , Widmayer MA , Browning JL , et al.   Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats . Stroke . 1994;25:2047–2054
  6. Birch PJ , Rogers H , Hayes AG , et al.   Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist . Br J Pharmacol . 1991;103:1819–1823
  7. Mackay KB , Kusumoto K , Graham DI , McCulloch J . Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat . Brain Res . 1993;629:10–18
  8. Genovese RF , Moreton JE , Tortella FC . Evaluation of neuroprotection and behavioral recovery by the kappa-opioid, PD117302 following transient forebrain ischemia . Brain Res Bull . 1994;34:111–116
  9. Itoh J , Ukai M , Kameyama T . U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice . Brain Res . 1993;619:223–228
  10. Butcher SP , Bullock R , Graham DI , McCulloch J . Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion . Stroke . 1990;21:1727–1733
  11. Matsumoto K , Graf R , Rosner G , et al.   Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia . Brain Res . 1992;579:309–314
  12. Matsumoto K , Graf R , Rosner G , et al.   Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia . J Cereb Blood Flow Metab . 1993;13:586–594
  13. Takagi K , Ginsberg MD , Globus MY , et al.   Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology . J Cereb Blood Flow Metab . 1993;13:575–585
  14. Wahl F , Obrenovitch TP , Hardy AM , et al.   Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency . J Neurochem . 1994;63:1003–1011
  15. Obrenovitch TP , Urenjak J . Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? . J Neurotrauma . 1997;14:677–698
  16. Kanter ED , Kapur A , Haberly LB . A dendritic GABAA-mediated IPSP regulates facilitation of NMDA-mediated responses to burst stimulation of afferent fibers in piriform cortex . J Neurosci . 1996;16:307–312
  17. Cross AJ , Snape MF , Green AR . Chlormethiazole antagonises seizures induced by N-methyl-DL-aspartate without interacting with the NMDA receptor complex . Psychopharmacology (Berl) . 1993;112:403–406
  18. Ohkuma S , Chen SH , Katsura M , et al.   Muscimol prevents neuronal injury induced by NMDA . Jpn J Pharmacol . 1994;64:125–128
  19. Thoren P , Sjolander M . Chlormethiazole attenuates the derangement of sensory evoked potential (SEP) induced by ICV administration of NMDA . Psychopharmacology (Berl) . 1993;111:256–258
  20. Zhang Z , Chen TY , Kirsch JR , et al.   Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats . Anesth Analg . 2003;97:1776–1783
  21. Chen TY , Goyagi T , Toung TJ , et al.   Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats . Stroke . 2004;35:1180–1185
  22. Chen CH , Toung TJ , Hurn PD , et al.   Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific . Stroke . 2005;36:1557–1561
  23. Schoffelmeer AN , Hogenboom F , Mulder AH . Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum . Br J Pharmacol . 1997;122:520–524
  24. Shippenberg TS , Chefer VI , Zapata A , Heidbreder CA . Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems . Ann N Y Acad Sci . 2001;937:50–73
  25. You ZB , Herrera-Marschitz M , Terenius L . Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides . J Pharmacol Exp Ther . 1999;290:1307–1315
  26. Goyagi T , Toung TJ , Kirsch JR , et al.   Neuroprotective kappaopioid receptor agonist BRL 52537 attenuates ischemiaevoked nitric oxide production in vivo in rats . Stroke . 2003;34:1533–1538
  27. Hjelmstad GO , Fields HL . Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms . J Neurophysiol . 2003;89:2389–2395
  28. Green AR , Hainsworth AH , Jackson DM . GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke . Neuropharmacology . 2000;39:1483–1494
  29. Schwartz-Bloom RD , Sah R . Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia . J Neurochem . 2001;77:353–371
  30. Globus MY , Busto R , Martinez E , et al.   Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat . J Neurochem . 1991;57:470–478
  31. Inglefield JR , Perry JM , Schwartz RD . Postischemic in hibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus . Hippocampus . 1995;5:460–468
  32. Phillis JW , Smith-Barbour M , Perkins LM , O'Regan MH . Characterization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex . Brain Res Bull . 1994;34:457–466
  33. Schwartz RD , Yu X , Katzman MR , et al.   Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum . J Neurosci . 1995;15:529–539
  34. Shuaib A , Ijaz S , Miyashita H , et al.   Progressive decrease in extracellular GABA concentrations in the post-ischemic period in the striatum: a microdialysis study . Brain Res . 1994;666:99–103

PII: S1016-3190(08)60051-8

doi:10.1016/S1016-3190(08)60051-8

Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 280-285, December 2008

Article Tools